Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Fischer Imaging SenoScan

This article was originally published in The Gray Sheet

Executive Summary

FDA approval for the full-field digital mammography system is anticipated within the next 30 days following an "approvable" letter from the agency, announced July 20. Unlike GE Medical's Senographe 2000D full-field digital mammography system, approved February 2000, the SenoScan was not subject to advisory panel review

You may also be interested in...

Fischer SenoScan Shipments Begin This Fall; 20% Market Share Sought

Fischer Imaging anticipates shipping 15-17 units of its SenoScan full-field digital mammography system by year-end. The firm believes it will have ramp-up capacity exceeding four to five units per month by mid-2002.

US FDA Still Seeking Sponsor Cooperation For Oncology Label Updates

Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts